Pharmacokinetics of intravenously administered caffeine in healthy alpacas (Lama pacos) and llamas (Lama glama). 2006

Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.

OBJECTIVE To determine the pharmacokinetic disposition of IV administered caffeine in healthy Lama spp camelids. METHODS 4 adult male alpacas and 4 adult female llamas. METHODS Caffeine (3 mg/kg) was administered as an IV bolus. Plasma caffeine concentrations were determined by use of high-performance liquid chromatography in 6 animals and by use of liquid chromatography-mass spectrometry in 2 llamas. RESULTS Median elimination half-life was 11 hours (range, 9.3 to 29.8 hours) in alpacas and 16 hours (range, 5.4 to 17 hours) in llamas. The volume of distribution at steady state was 0.60 L/kg (range, 0.45 to 0.93 L/kg) in alpacas and 0.75 L/kg (range, 0.68 to 1.15 L/kg) in llamas. Total plasma clearance was 44 mL/h/kg (range, 24 to 56 mL/h/kg) in alpacas and 42 mL/h/kg (range, 30 to 109 mL/h/kg) in llamas. CONCLUSIONS High-performance liquid chromatography and liquid chromatography-mass spectrometry were suitable methods for determination of plasma caffeine concentrations in alpacas and llamas. Plasma caffeine concentration-time curves were best described by a 2-compartment model. Elimination half-lives, plasma clearance, volume of distribution at steady state, and mean residence time were not significantly different between alpacas and llamas. Intravenous administration of caffeine at a dose of 3 mg/kg did not induce clinical signs of excitement.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002161 Camelids, New World Camelidae of the Americas. The extant species are those originating from South America and include alpacas, llamas, guanicos, and vicunas. Alpacas,Guanacos,Llamas,Lama glama,Lama glama guanicoe,Lama guanicoe,Lama pacos,Vicugna pacos,Vicugna vicugna,Vicunas,Alpaca,Camelid, New World,Guanaco,Llama,New World Camelid,New World Camelids,Vicuna
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006262 Health The state of the organism when it functions optimally without evidence of disease. Individual Health,Normalcy,Normality,Health, Individual,Normalcies,Normalities
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
June 2004, Journal of veterinary pharmacology and therapeutics,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
January 2000, Veterinary ophthalmology,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
April 2001, Animal reproduction science,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
April 2024, Veterinary research communications,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
August 2004, The Journal of parasitology,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
August 1992, Tierarztliche Praxis,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
July 2020, Veterinary parasitology,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
March 2002, The Veterinary record,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
January 2005, Journal of veterinary internal medicine,
Jeffrey Lakritz, and John R Middleton, and David E Anderson, and Daniel R Linden, and Richard A Sams, and Ronald K Tessman, and Jeff W Tyler
October 2011, American journal of veterinary research,
Copied contents to your clipboard!